These changes were accompanied by an increase in tumor-infiltrating CD11b, CD4, and CD8 cells and a decrease in FoxP3 cells, indicating that elimination of tumor-expressed PROS1 changed the immune infiltrate. This evidence concerns the gene FOXP3 and neoplasm.